Edmond de Rothschild (Europe)’s Bristol-Myers Squibb BMY Stock Holding History

Edmond de Rothschild (Europe)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$90K	Buy	+1,670	New	+$107K	0.04%	137

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Edmond de Rothschild (Europe)'s BMY Position: Q3 2016 in Review

Edmond de Rothschild (Europe) opened a new position in Bristol-Myers Squibb (BMY) in Q3 2016: 1,670 shares worth $90K. The stake represents 0.04% of the portfolio and ranks #137 among its holdings.

1,523 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

Edmond de Rothschild (Europe) held 1,670 shares of Bristol-Myers Squibb worth $90K as of Q3 2016.
Bristol-Myers Squibb was a new Edmond de Rothschild (Europe) position in Q3 2016.
Bristol-Myers Squibb made up 0.04% of Edmond de Rothschild (Europe)'s portfolio in Q3 2016, its #137 holding.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q3 2016, filed 14 Nov 2016.